November 2024

RAYDIAX won Saxony-Anhalt Business Award 2024

RAYDIAX won Saxony-Anhalt Business Award 2024

🎉 It is a great honor for us to have won the Saxony-Anhalt Business Award 2024 in the start-up category.

This award is an extraordinary recognition for us as a team and our efforts to further strengthen interventional oncology and make a positive impact worldwide 🌍.

Our congratulations also go to our neighbouring startup, mediMESH, for winning the special prize!

We would also like to take this opportunity to thank our supporters:

👉 First and foremost, the Forschungscampus STIMULATE and Otto-von-Guericke-Universität Magdeburg, in particular Prof. Georg Rose.
👉 The state of Saxony-Anhalt and the federal government: Without the long-term commitment to medical technology excellence, we would not exist.
👉 The EXIST - Existenzgründungen aus der Wissenschaft programme by Bundesministerium für Wirtschaft und Klimaschutz which provided the basis for our company through pre-seed deep-tech financing.

Last but not least - and of course, this award belongs to them as well - a big thank you to all our existing shareholders and fund investors HTGF | High-Tech Gründerfonds and bmp Ventures-Ventures as well as our business angels for their trust and support!We take the time to celebrate 🥂 so that we can work even harder to realise our vision for the future of interventional oncology! 🚀

Last Articles

Stay informed!

Join our newsletter to stay informed about our latest updates, valuable technical and clinical insights and future events directly in your inbox. Follow our journey to revolutionize the world of minimally invasive therapies.
Sign up today and become part of our community!

Ready for Innovation?

We know that the methods of minimally invasive therapies continue to offer great potential for clinical innovation. Would you also like to establish your operating technique? Make a suggestion, define a joint project and research your case on our system in phantom studies. And of course we are open to clinical publications.